Nervonik Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$52.5M
- Investors
-
16
Nervonik General Information
Description
Developer of a neuro-modulation device designed for therapeutic applications. The company utilizes proprietary wireless power delivery, miniaturized implantable leads, and integrated sensing circuits to provide real-time physiological feedback and closed-loop stimulation parameters tailored to individual patient needs, enabling patients to access an opioid-free, minimally invasive alternative to traditional spinal cord stimulators and pharmaceutical interventions for long-term neuropathic relief.
Contact Information
Website
www.nervonik.comCorporate Office
- 11965 Gorham Avenue
- Suite 301
- Los Angeles, CA 90049
- United States
Corporate Office
- 11965 Gorham Avenue
- Suite 301
- Los Angeles, CA 90049
- United States
Nervonik Timeline
Nervonik Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series B) | 20-Apr-2026 | $52.5M | Completed | Generating Revenue | ||
| 4. Later Stage VC (Series A) | 27-Feb-2025 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 05-Mar-2024 | Completed | Startup | |||
| 2. Early Stage VC (Series A) | 01-Aug-2021 | $1.6M | $1.6M | Completed | Startup | |
| 1. University Spin-Out | 23-Oct-2020 | Completed | Startup |
Nervonik Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A-4 | ||||||||
| Series A-3 | ||||||||
| Series A-2 | 70,279 | $0.000010 | $0.06 | $0.75 | $0.75 | 1x | $0.75 | 0.31% |
| Series A-1 | 3,343,472 | $0.000010 | $0.31 | $3.89 | $3.89 | 1x | $3.89 | 14.67% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Nervonik Patents
Nervonik Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026231643-A1 | Connector assemblies for medical devices | Pending | 01-May-2025 | ||
| EP-4655053-A1 | Systems and methods for external control of power transmission to, and stimulation therapy by, an implanted neuromodulation device | Pending | 24-Jan-2023 | ||
| US-20260115474-A1 | Systems and methods for external control of power transmission to, and stimulation therapy by, an implanted neuromodulation device | Pending | 24-Jan-2023 | ||
| WO-2024158670-A1 | Systems and methods for external control of power transmission to, and stimulation therapy by, an implanted neuromodulation device | Inactive | 24-Jan-2023 | ||
| WO-2024158670-A9 | Systems and methods for external control of power transmission to, and stimulation therapy by, an implanted neuromodulation device | Inactive | 24-Jan-2023 | A61N1/0551 |
Nervonik Signals
Nervonik Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Amzak Health | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Elevage Medical Technologies | Growth/Expansion | Minority | ||
| Lumira Ventures | Venture Capital | Minority | ||
| Correlation Ventures | Venture Capital | Minority |
Nervonik FAQs
-
When was Nervonik founded?
Nervonik was founded in 2020.
-
Where is Nervonik headquartered?
Nervonik is headquartered in Los Angeles, CA.
-
What is the size of Nervonik?
Nervonik has 12 total employees.
-
What industry is Nervonik in?
Nervonik’s primary industry is Therapeutic Devices.
-
Is Nervonik a private or public company?
Nervonik is a Private company.
-
What is the current valuation of Nervonik?
The current valuation of Nervonik is .
-
What is Nervonik’s current revenue?
The current revenue for Nervonik is .
-
How much funding has Nervonik raised over time?
Nervonik has raised $70M.
-
Who are Nervonik’s investors?
Amzak Health, , Elevage Medical Technologies, Lumira Ventures, and Correlation Ventures are 5 of 16 investors who have invested in Nervonik.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process